Published in Cancer Cell · View the paper (DOI)
A team of researchers has identified an alternate mechanism for evading therapy in brain cancer cells, which adapts within as little as three days of treatment. By targeting both the original and new signaling pathways, they can durably suppress tumor growth.
Coverage from 2 institutions
- A different route to drug resistance Ludwig Institute for Cancer Research · Apr 11, 2016 · first to report
- Mapping the routes to drug resistance in cancer Cell Press · Apr 11, 2016